Clinical Trial for the Prevention of Vasovagal Syncope
Completed
Canadian Institutes of Health Research (CIHR)
Phase 4
2005-05-01
The main question in the study is whether people taking fludrocortisone are less likely to
faint than people taking an inactive pill called a placebo.
Fludrocortisone is a drug that stimulates the body to retain salt and water. The
investigators know from some studies that it might prevent people from fainting at home and
in the community, while they are carrying on with their lives. There is some evidence that
salt and water retention help prevent fainting, but no one has a clear idea about whether
this is true. This study will try to determine if that is true.
Clinical Trial for the Prevention of Vasovagal Syncope
Completed
University of Calgary
Phase 4
2005-05-01
The main question in the study is whether people taking fludrocortisone are less likely to
faint than people taking an inactive pill called a placebo.
Fludrocortisone is a drug that stimulates the body to retain salt and water. The
investigators know from some studies that it might prevent people from fainting at home and
in the community, while they are carrying on with their lives. There is some evidence that
salt and water retention help prevent fainting, but no one has a clear idea about whether
this is true. This study will try to determine if that is true.
A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Completed
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 1
2011-12-01
The purpose of this study is to determine the minimum dose of abiraterone acetate needed to
decrease serum androstenedione to age-appropriate levels in premenopausal women on steroid
replacement for classic 21-hydroxylase deficiency.
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
Completed
Fundação de Amparo à Pesquisa do Estado de São Paulo
Phase 4
2014-08-01
The purpose of this study is to assess whether the switch from branded to generic warfarin or
between different generic warfarin tablets may cause fluctuation in the results of
coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing
them to unnecessary risks.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
